Amgen Inc.

American Science and Engineering, Inc.

Charles C Squires

Jordan Smith

Michael J Ottomanelli

Robert C Thompson

Rebecca W Vanderslice

Tadahiko Kohno

Michael T Brewer

Alex Chalmers

James Vannice

Michael W King

Karin K Hale

An apparatus for stowing and/or transporting rod-shaped structures such that the rods are easily insertable into, and removable from, the rod holder when it is located underneath an overhead obstruction that would otherwise prevent insertion or removal of rods into the rod holder. The rod holder rotates away from the receiving structure to which it is attached by operation of a rotatable attachment between the rod holder and a base. The base comprises a latching mechanism to prevent the rod holder from rotating unless it is released using a latch release lever. The rod holder allows insertion of longer rods into the rod holder than would otherwise be possible using rod holders of the prior art. The rod holder increases ease of access to rods stored in the rod holder. An exemplary use case is the storage of fishing rods under a T-top on a fishing boat.

Rotating rod holder

Rod holder

An apparatus for inspecting a physical object in a nautical environment includes a radiation source capable of directing a beam of penetrating radiation toward the physical object, and a detector capable of detecting the reaction of the physical object to the penetrating radiation. In addition to detecting the reaction, the detector is capable of delivering an output signal characterizing the physical object. Accordingly, the output signal is based upon the reaction of the physical object to the penetrating radiation.

Nautical X-ray inspection system

At least two substantially purified tumor necrosis factor (TNF) inhibitors are disclosed which are glycoproteins that are active against TNF. The isolation of 3O kDa and 40 KDa TNF inhibitor from urine is disclosed. The deglycosylated form of the 3O kDa TNF inhibitor and 40 kDa TNF inhibitor are described as being active against TNF. The 40 kDa TNF inhibitor is active against both TNF alpha a TNF beta. The amino acid sequence of the 30 kDa TNF inhibitor and the 40 kDa TNF inhibitor are disclosed. Methods for isolating the TNF inhibitors from human U937 cell medium and producing the proteins by recombinant-DNA methods are also described.

Tumor necrosis factor (TNF) inhibitor and method for obtaining the same

Growing community of inventors

McKinney, TX, United States of America

Charles C Squires